Article
Medicine, General & Internal
Lea Penzkofer, Jens Mittler, Stefan Heinrich, Nicolas Wachter, Beate K. Straub, Roman Kloeckner, Fabian Stoehr, Simon Johannes Gairing, Fabian Bartsch, Hauke Lang
Summary: Liver cirrhosis is a common risk factor for hepatocellular carcinoma (HCC), but a small percentage of HCC cases occur in non-cirrhotic livers. This study found that liver resection for non-cirrhotic HCC is an acceptable treatment approach with relatively good outcomes, even for extensive tumors.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Surgery
Haili Zhang, Fei Liu, Ningyuan Wen, Bo Li, Yonggang Wei
Summary: This study found that intrahepatic recurrence was still the most common pattern after LLR for HCC, with most recurrences occurring within 2 years. There were no significant differences in recurrence patterns, timing, or treatment between LLR and OLR, with independent risk factors for recurrence including ALBI grade, postoperative alpha-fetoprotein levels, tumor size, surgical margins, and multiple tumors.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2022)
Article
Surgery
Xin-Fei Xu, Yong-Kang Diao, Yong-Yi Zeng, Chao Li, Feng-Wei Li, Li-Yang Sun, Han Wu, Kong-Ying Lin, Lan-Qing Yao, Ming-Da Wang, Cheng-Wu Zhang, Wan Yee Lau, Feng Shen, Tian Yang
Summary: This study investigated the relationship between the severity in the grading of microvascular invasion (MVI) and long-term oncological outcomes in patients with early-stage hepatocellular carcinoma (HCC). The results showed that the severity in MVI grading was independently associated with recurrence and survival after HCC resection. Patients with a more severe MVI grading (M2) require more stringent recurrence surveillance and/or active adjuvant therapy against recurrence.
INTERNATIONAL JOURNAL OF SURGERY
(2023)
Article
Medicine, General & Internal
Indah Jamtani, Kwang-Woong Lee, Yunhee Choi, YoungRok Choi, Jeong-Moo Lee, Eui-Soo Han, Kwangpyo Hong, Gyu-Seong Choi, Jong Man Kim, Nam-Joon Yi, Suk Kyun Hong, Jeik Byun, Su Young Hong, Sanggyeun Suh, Jae-Won Joh, Kyung-Suk Suh
Summary: This study aimed to develop a tailored prediction model of HCC-specific survival after transplantation, validated internally and externally. By combining multiple risk factors, the model showed good accuracy in predicting HCC-specific survival tailored for patients undergoing transplantation. The calculated SALT predictor provided accurate information on expected survival rates based on risk scores and specific characteristics.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Gastroenterology & Hepatology
Xin-Fei Xu, Han Wu, Ju-Dong Li, Lan-Qing Yao, Bin Huang, Yong-Kang Diao, Ting-Hao Chen, Wei-Min Gu, Zhong Chen, Jie Li, Yao-Ming Zhang, Hong Wang, Ying-Jian Liang, Ya-Hao Zhou, Chao Li, Ming-Da Wang, Cheng-Wu Zhang, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
Summary: This study found that the prognosis of solitary huge hepatocellular carcinoma (HCC) is associated with tumor morphology, with patients having balloon-shaped HCC (BS-HCC) showing better long-term survival after liver resection. This finding helps guide the treatment strategy for patients with solitary huge HCC.
HEPATOBILIARY SURGERY AND NUTRITION
(2023)
Article
Oncology
Shi-Ye Yang, Mao-Lin Yan, Jin-Kai Feng, Yun-Fei Duan, Jia-Zhou Ye, Zong-Han Liu, Lei Guo, Jie Xue, Jie Shi, Wan Yee Lau, Shu-Qun Cheng, Wei-Xing Guo
Summary: This study found that patients with type 2 diabetes mellitus (T2DM) had worse prognoses compared to those without T2DM after laparoscopic liver resection (LLR). Preoperative T2DM was identified as an independent risk factor for overall survival (OS) and recurrence-free survival (RFS) in hepatocellular carcinoma (HCC) patients. Therefore, patients with concurrent HCC and T2DM should be closely monitored after LLR.
FRONTIERS IN ONCOLOGY
(2022)
Article
Surgery
Masateru Yamamoto, Tsuyoshi Kobayashi, Naruhiko Honmyo, Akihiko Oshita, Tomoyuki Abe, Toshihiko Kohashi, Takashi Onoe, Saburo Fukuda, Ichiro Omori, Yasuhiro Imaoka, Hideki Ohdan
Summary: Patients with hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer criteria can benefit from liver resection based on a predictive formula that considers a high a-fetoprotein level, macrovascular invasion, and high total tumor burden. Risk stratification using these factors can predict the prognosis and guide treatment decisions.
Article
Oncology
Zhancheng Qiu, Weili Qi, Youwei Wu, Lingling Li, Chuan Li
Summary: This study examines the impact of public insurance status on the survival outcomes of HCC patients after liver resection in China. The results show that underinsured HCC patients have worse survival outcomes after liver resection. This may be due to the limited access to care for underinsured patients, but further exploration is needed for conclusive evidence.
Article
Gastroenterology & Hepatology
Shi-Chuan Tang, Kai-Ling Zhang, Kong-Ying Lin, Yi-Dan Tang, Jun Fu, Wei-Ping Zhou, Jian-Xi Zhang, Jie Kong, Xiao-Lu He, Zheng-Hong Sun, Cong Luo, Hong-Zhi Liu, Yong-Ping Lai, Yong-Yi Zeng
Summary: This study demonstrated that anatomical resection decreases the risk of tumor recurrence and improves overall survival (OS) and recurrence-free survival (RFS) in patients with early-stage hepatocellular carcinoma (HCC). Anatomical resection should be adopted as long as such a surgical maneuver is feasible for initial treatment of early-stage HCC.
HEPATOLOGY INTERNATIONAL
(2023)
Article
Oncology
Hang-Dong Jia, Lei Liang, Chao Li, Han Wu, Hong Wang, Ying-Jian Liang, Ya-Hao Zhou, Wei-Min Gu, Xin-Ping Fan, Wan-Guang Zhang, Ting-Hao Chen, Zhi-Yu Chen, Jian-Hong Zhong, Wan Yee Lau, Timothy M. Pawlik, Yong-Kang Diao, Qiu-Ran Xu, Feng Shen, Cheng-Wu Zhang, Dong-Sheng Huang, Tian Yang
Summary: Patients with HBV/HCV-HCC had poorer long-term surgical outcomes after liver resection compared to those with HBV-HCC, with significantly lower recurrence-free survival and overall survival rates.
FRONTIERS IN ONCOLOGY
(2021)
Article
Multidisciplinary Sciences
Nanping Lin, Lei Wang, Qizhen Huang, Weiping Zhou, Xiaolong Liu, Jingfeng Liu
Summary: This study developed a nomogram model to predict the overall survival of hepatocellular carcinoma patients who underwent R0 resection. The model showed good calibration and discriminatory power, and it was found that p-TACE could significantly prolong the median overall survival in high-risk patients.
Article
Oncology
Dongsub Jeon, Won-Mook Choi, Jin-Sun Kim, Yusun Jung, Su-Yeon Lee, Haeng Ran Seo, Kang Mo Kim
Summary: This study found that serum sorbitol dehydrogenase (SORD) levels were associated with the length of recurrence-free survival after surgical resection for HCC, with higher SORD levels (>= 15 ng/mL) being linked to a shorter recurrence-free survival. When combined with AFP levels, SORD levels could better predict the prognosis in HCC patients.
Article
Oncology
Cheng-Maw Ho, Chih-Hsin Lee, Ming-Chia Lee, Jun-Fu Zhang, Chin-Hua Chen, Jann-Yuan Wang, Rey-Heng Hu, Po-Huang Lee
Summary: This study analyzed the survival of patients with post-transplant HCC recurrence, finding that early recurrence within two years after surgery had a poorer prognosis compared to late recurrence. Factors such as transplant era before 2008 and radiofrequency ablation were associated with better outcomes, while receiving sorafenib and radiotherapy were linked to poorer prognosis.
FRONTIERS IN ONCOLOGY
(2021)
Article
Multidisciplinary Sciences
Jing-Houng Wang, Wei-Feng Li, Chee-Chien Yong, Yueh-Wei Liu, Sheng-Nan Lu, Chih-Chi Wang
Summary: This study investigated the role of LS and metabolic factors in predicting HCC recurrence for patients with early stage HCC. It was found that LS was positively correlated with fibrosis stage, and patients with LS>8.5 kPa and HOMA-IR>2.3 had the highest recurrence rate after 1-year post resection.
SCIENTIFIC REPORTS
(2021)
Article
Surgery
Yueh-Wei Liu, Chee-Chien Yong, Chih-Che Lin, Chih-Chi Wang, Chao-Long Chen, Yu-Fan Cheng, Jing-Houng Wang, Yi-Hao Yen
Summary: In a retrospective study on patients who underwent liver resection for hepatocellular carcinoma, it was found that 6 months was identified as the optimal cutoff time point to differentiate early versus late recurrence. Early recurrence within 6 months was associated with worse post-recurrence survival and overall survival compared to late recurrence beyond 6 months.
UPDATES IN SURGERY
(2021)
Article
Surgery
Hao Xing, Li-Yang Sun, Wen-Tao Yan, Bing Quan, Lei Liang, Chao Li, Ya-Hao Zhou, Hong Wang, Jian-Hong Zhong, Wei-Min Gu, Ting-Hao Chen, Ming-Da Wang, Han Wu, Timothy M. Pawlik, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang
Summary: The study showed that patients who underwent repeat hepatectomy for early recurrence of hepatocellular carcinoma had worse overall survival and disease-free survival compared to those with late recurrence. These findings can provide guidance for physicians in selecting patients for repeat hepatectomy.
Article
Surgery
Ju-Dong Li, Yong-Kang Diao, Jie Li, Han Wu, Li-Yang Sun, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Yong-Yi Zeng, Ya-Hao Zhou, Yu Wang, Yao-Ming Zhang, Ying-Jian Liang, Wan Yee Lau, Chao Li, Lei Liang, Ming-Da Wang, Cheng-Wu Zhang, Feng Shen, Cheng-Hao Shao, Tian Yang
Summary: The study found that preoperative prealbumin level was associated with postoperative mortality and morbidity for patients undergoing hepatic resection for HCC, with the low prealbumin group showing higher rates of adverse events. Prealbumin level could serve as an important predictor for postoperative outcomes in these patients.
AMERICAN JOURNAL OF SURGERY
(2021)
Editorial Material
Medicine, Research & Experimental
Xin-Fei Xu, Lei Liang, Hao Xing, Feng Shen, Dong-Sheng Huang, Wan Yee Lau, Tian Yang
BIOMARKERS IN MEDICINE
(2021)
Review
Chemistry, Multidisciplinary
Han Wu, Ming-Da Wang, Lei Liang, Hao Xing, Cheng-Wu Zhang, Feng Shen, Dong-Sheng Huang, Tian Yang
Summary: Nanotechnology has gained extensive attention in surveillance, imaging, and treatment of hepatocellular carcinoma. Nanomedicines focus on early diagnosis and precise treatment of HCC, offering promising potential applications in future clinical practice.
Article
Surgery
Yong-Kang Diao, Jun-Wei Liu, Han Wu, Ming-Da Wang, Xin-Ping Fan, Ting-Hao Chen, Jian-Yu Wang, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Jie Li, Ying-Jian Liang, Zhi-Yu Chen, Wan Yee Lau, Lei Liang, Chao Li, Cheng-Wu Zhang, Feng Shen, Dong-Sheng Huang, Tian Yang
Summary: Adolescents and young adults (AYAs) in areas with endemic hepatitis B virus infection are more likely to develop hepatocellular carcinoma (HCC). After undergoing HCC resection, AYAs have a higher risk of recurrence than older adults, indicating a need for enhanced surveillance for postoperative recurrence among AYAs.
AMERICAN JOURNAL OF SURGERY
(2021)
Article
Gastroenterology & Hepatology
Lei Liang, Bing Quan, Han Wu, Yong-Kang Diao, Jie Li, Ting-Hao Chen, Yao-Ming Zhang, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Matteo Serenari, Matteo Cescon, Myron Schwartz, Yong-Yi Zeng, Ying-Jian Liang, Hang-Dong Jia, Hao Xing, Chao Li, Ming-Da Wang, Wen-Tao Yan, Wan-Yuan Chen, Wan Yee Lau, Cheng-Wu Zhang, Timothy M. Pawlik, Dong-Sheng Huang, Feng Shen, Tian Yang
Summary: An individualized patient-specific tool was developed and validated to predict the benefit of surgery for hepatocellular carcinoma (HCC) patients. The tool showed good performance in identifying patients at highest risk of death within 6 months of surgery, which may help guide surgical decision-making to avoid futile surgery.
HEPATOLOGY INTERNATIONAL
(2021)
Article
Oncology
Lei Liang, Ming-Da Wang, Yao-Ming Zhang, Wan-Guang Zhang, Cheng-Wu Zhang, Wan Yee Lau, Feng Shen, Timothy M. Pawlik, Dong-Sheng Huang, Tian Yang
Summary: This study investigated long-term recurrence and survival after hepatectomy for high-AFP HCC, finding that postoperative incomplete biomarker response was the strongest risk factor for predicting poor overall survival and recurrence-free survival in these patients.
JOURNAL OF HEPATOCELLULAR CARCINOMA
(2021)
Letter
Gastroenterology & Hepatology
Li-Yang Sun, Hang-Dong Jia, Lei Liang, Dong-Sheng Huang, Tian Yang
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2022)
Article
Oncology
Lan-Qing Yao, Zhen-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
Summary: This study investigates the clinical features and long-term prognosis of patients with hepatocellular carcinoma (HCC) who experienced recurrence after curative hepatic resection. The results show that nearly half of the patients experienced recurrence, and several factors such as cirrhosis, preoperative alpha-fetoprotein level, and tumor size are associated with postoperative recurrence. Treatment modalities and regular surveillance after recurrence can significantly impact patient survival.
ANNALS OF SURGICAL ONCOLOGY
(2022)
Article
Oncology
Zheng-Liang Chen, Lan-Qing Yao, Jia-Le Pu, Han Wu, Xin-Fei Xu, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Zhi-Yu Chen, Li-Yang Sun, Yong-Kang Diao, Jian-Hong Zhong, Wan Yee Lau, Timothy M. Pawlik, Dong-Sheng Huang, Feng Shen, Ying-Jian Liang, Tian Yang
Summary: This study compared the outcomes of partial hepatectomy in patients with HCC and CSPH with or without concurrent CSED. The results showed that patients who underwent CSED had better overall survival and lower rate of variceal bleeding compared to those without CSED.
Editorial Material
Oncology
Lan-Qing Yao, Zhen-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
ANNALS OF SURGICAL ONCOLOGY
(2022)
Correction
Oncology
Lan-Qing Yao, Zheng-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
ANNALS OF SURGICAL ONCOLOGY
(2022)
Review
Pharmacology & Pharmacy
Han Wu, Ming-Da Wang, Jia-Qi Zhu, Zhen-Li Li, Wan-Yin Wang, Li-Hui Gu, Feng Shen, Tian Yang
Summary: Liver cancer is the seventh-most-common cancer worldwide and the fourth-leading cause of cancer mortality. Mesoporous nanoparticles have been developed as specific carriers for drugs and imaging agents in the diagnosis and treatment of liver cancer. The design of mesoporous nanoparticles has greatly improved their drug-loading efficiency, biocompatibility, and biodegradability. This review summarizes the advanced designs of mesoporous nanoparticles in the different diagnostic and therapeutic fields of liver cancer and discusses their advantages and disadvantages in application.
Article
Gastroenterology & Hepatology
Xin-Fei Xu, Han Wu, Ju-Dong Li, Lan-Qing Yao, Bin Huang, Yong-Kang Diao, Ting-Hao Chen, Wei-Min Gu, Zhong Chen, Jie Li, Yao-Ming Zhang, Hong Wang, Ying-Jian Liang, Ya-Hao Zhou, Chao Li, Ming-Da Wang, Cheng-Wu Zhang, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
Summary: This study found that the prognosis of solitary huge hepatocellular carcinoma (HCC) is associated with tumor morphology, with patients having balloon-shaped HCC (BS-HCC) showing better long-term survival after liver resection. This finding helps guide the treatment strategy for patients with solitary huge HCC.
HEPATOBILIARY SURGERY AND NUTRITION
(2023)
Article
Gastroenterology & Hepatology
Wen-Tao Yan, Chao Li, Lan-Qing Yao, Hai-Bo Qiu, Ming-Da Wang, Xin-Fei Xu, Ya-Hao Zhou, Hong Wang, Ting-Hao Chen, Wei-Min Gu, Jian-Hong Zhong, Han Wu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
Summary: This study identified predictors and long-term prognosis of early and late recurrence after hepatic resection for hepatocellular carcinoma (HCC). Results showed that there were different independent predictors associated with early and late recurrence, with patients experiencing early recurrence having poorer long-term survival compared to those with late recurrence.
HEPATOBILIARY SURGERY AND NUTRITION
(2021)